Opaleye Management Inc.

Insider Reports History

Reporting-owner location: Boston, MA
Latest reporting-owner signature: Opaleye Management, Inc., By: /s/ James Silverman, President
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Opaleye Management Inc.

Form 4 holding 10%+ Owner

HARROW, INC.

Security class: Common Stock, par value $0.001 per share
Shares / value: 3,622,000
Estimated value: $143,692,346
Report date: 04 Mar 2026
Price: $39.67
Ownership: By Opaleye, L.P.

Form 4 holding 10%+ Owner

Eton Pharmaceuticals, Inc.

Security class: Common Stock, par value $0.001 per share
Shares / value: 2,665,000
Estimated value: $100,052,361
Report date: 14 Jul 2026
Price: $37.54
Ownership: By Opaleye, L.P.

Form 4 holding 10%+ Owner

Sol-Gel Technologies Ltd.

Security class: Ordinary Shares, par value NIS 1.00 per share
Shares / value: 494,887
Estimated value: $35,384,420
Report date: 12 Aug 2026
Price: $71.50
Ownership: By Opaleye, L.P.

Form 4 holding 10%+ Owner

Alpha Cognition Inc.

Security class: Common Stock, no par value
Shares / value: 3,048,223
Estimated value: $24,385,784
Report date: 03 Aug 2026
Price: $8.00
Ownership: By Opaleye, L.P.

Form 4 holding 10%+ Owner

CODEXIS, INC.

Security class: Common Stock, par value $0.001 per share
Shares / value: 9,955,000
Estimated value: $16,599,962
Report date: 01 Dec 2025
Price: $1.67
Ownership: By Opaleye, L.P.

Form 4 holding 10%+ Owner

SANUWAVE Health, Inc.

Security class: Common Stock, par value $0.001 per share
Shares / value: 853,569
Estimated value: $13,751,423
Report date: 01 May 2026
Price: $16.11
Ownership: By Opaleye, L.P.

Form 4 holding Former 10% Owner.

TELA Bio, Inc.

Security class: Common Stock, par value $0.001 per share
Shares / value: 1,948,000
Estimated value: $11,005,031
Report date: 20 Apr 2023
Price: $5.65
Ownership: By Opaleye, L.P.

Form 4 holding 10%+ Owner

Grace Therapeutics, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 2,760,000
Estimated value: $5,755,428
Report date: 14 Aug 2026
Price: $2.09
Ownership: By Opaleye, L.P.

Form 4 holding 10%+ Owner

Protara Therapeutics, Inc.

Security class: Common Stock, par value $0.001 per share
Shares / value: 1,944,134
Estimated value: $3,322,331
Report date: 12 Sep 2024
Price: $1.71
Ownership: By Opaleye, L.P.

Form 4 holding 10%+ Owner

HARROW, INC.

Security class: Common Stock, par value $0.001 per share
Shares / value: 59,428
Estimated value: $2,357,633
Report date: 04 Mar 2026
Price: $39.67
Ownership: By Managed Account

Form 4 holding 10%+ Owner

Eton Pharmaceuticals, Inc.

Security class: Common Stock, par value $0.001 per share
Shares / value: 40,000
Estimated value: $1,501,724
Report date: 14 Jul 2026
Price: $37.54
Ownership: By Managed Account

Form 4 holding 10%+ Owner

Eton Pharmaceuticals, Inc.

Security class: Common Stock, par value $0.001 per share
Shares / value: 85,000
Estimated value: $1,345,031
Report date: 10 Jun 2025
Price: $15.82
Ownership: Managed Account

Form 4 holding 10%+ Owner

Sol-Gel Technologies Ltd.

Security class: Ordinary Shares, par value NIS 1.00 per share
Shares / value: 15,000
Estimated value: $1,112,100
Report date: 12 Aug 2026
Price: $74.14
Ownership: By Managed Account

Form 4 holding 10%+ Owner

Alpha Cognition Inc.

Security class: Common Stock, no par value
Shares / value: 100,000
Estimated value: $722,000
Report date: 31 Jul 2026
Price: $7.22
Ownership: By Managed Account

Form 4 holding Former 10% Owner.

TELA Bio, Inc.

Security class: Common Stock, par value $0.001 per share
Shares / value: 124,813
Estimated value: $705,119
Report date: 20 Apr 2023
Price: $5.65
Ownership: By Managed Account

Form 4 holding 10%+ Owner

CODEXIS, INC.

Security class: Common Stock, par value $0.001 per share
Shares / value: 179,989
Estimated value: $300,131
Report date: 01 Dec 2025
Price: $1.67
Ownership: By Managed Account

Form 4 holding 10%+ Owner

SANUWAVE Health, Inc.

Security class: Common Stock, par value $0.001 per share
Shares / value: 5,000
Estimated value: $80,552
Report date: 01 May 2026
Price: $16.11
Ownership: By Managed account

Form 4 holding 10%+ Owner

Protara Therapeutics, Inc.

Security class: Common Stock, par value $0.001 per share
Shares / value: 45,000
Estimated value: $76,901
Report date: 12 Sep 2024
Price: $1.71
Ownership: By Managed account

Form 4 holding 10%+ Owner

Tracon Pharmaceuticals, Inc.

Security class: Prefunded Warrants
Shares / value: 2,013,999
Estimated value
Report date: 10 Nov 2023
Price
Ownership: By Opaleye, L.P.
Underlying class: Common Stock
Underlying amount: 2,013,999

Form 4 holding 10%+ Owner

Tracon Pharmaceuticals, Inc.

Security class: Common Stock, par value $0.001 per share
Shares / value: 0
Estimated value
Report date: 10 Nov 2023
Price: $0.2942
Ownership: By Managed account

Form 4 holding 10%+ Owner

Tracon Pharmaceuticals, Inc.

Security class: Common Stock, par value $0.001 per share
Shares / value: 0
Estimated value
Report date: 10 Nov 2023
Price: $0.2942
Ownership: By Opaleye, L.P.

Insider Reports Filed by Opaleye Management Inc.

4 GRCE

Grace Therapeutics, Inc.

Report period: 14 Aug 2026
Transactions: 1
Transaction value: +$24,206
Accepted by SEC: 19 Aug 2026, 07:44
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 12 Aug 2026
Transactions: 1
Transaction value: +$67,996
Accepted by SEC: 14 Aug 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 31 Jul 2026
Transactions: 2
Transaction value: +$422,976
Accepted by SEC: 04 Aug 2026, 16:50
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 24 Jul 2026
Transactions: 1
Transaction value: +$1,027
Accepted by SEC: 28 Jul 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 22 Jul 2026
Transactions: 3
Transaction value: +$1,565,499
Accepted by SEC: 24 Jul 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4/A ETON

Eton Pharmaceuticals, Inc.

Report period: 14 Jul 2026
Transactions: 2
Transaction value: -$1,063,033
Accepted by SEC: 17 Jul 2026, 19:12
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 13 Jul 2026
Transactions: 2
Transaction value: +$124,819
Accepted by SEC: 15 Jul 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 08 Jul 2026
Transactions: 2
Transaction value: +$39,042
Accepted by SEC: 10 Jul 2026, 16:41
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 02 Jul 2026
Transactions: 5
Transaction value: -$4,768,637
Accepted by SEC: 07 Jul 2026, 18:29
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 01 Jul 2026
Transactions: 2
Transaction value: +$123,220
Accepted by SEC: 02 Jul 2026, 18:11
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 25 Jun 2026
Transactions: 2
Transaction value: +$976,490
Accepted by SEC: 29 Jun 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 11 Jun 2026
Transactions: 3
Transaction value: +$45,773
Accepted by SEC: 15 Jun 2026, 20:10
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 09 Jun 2026
Transactions: 2
Transaction value: +$183,692
Accepted by SEC: 11 Jun 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 05 Jun 2026
Transactions: 1
Transaction value: +$58,596
Accepted by SEC: 09 Jun 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 27 May 2026
Transactions: 3
Transaction value: +$434,714
Accepted by SEC: 29 May 2026, 19:21
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 20 May 2026
Transactions: 2
Transaction value: +$140,545
Accepted by SEC: 22 May 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 20 May 2026
Transactions: 1
Transaction value: +$100,712
Accepted by SEC: 22 May 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 15 May 2026
Transactions: 2
Transaction value: +$196,009
Accepted by SEC: 19 May 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 12 May 2026
Transactions: 2
Transaction value: +$231,502
Accepted by SEC: 14 May 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SNWV

SANUWAVE Health, Inc.

Report period: 30 Apr 2026
Transactions: 4
Transaction value: -$574,240
Accepted by SEC: 04 May 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SNWV

SANUWAVE Health, Inc.

Report period: 28 Apr 2026
Transactions: 4
Transaction value: -$1,274,971
Accepted by SEC: 30 Apr 2026, 16:10
Role: 10%+ Owner
Next action: Open filing details

4 SNWV

SANUWAVE Health, Inc.

Report period: 17 Apr 2026
Transactions: 3
Transaction value: -$336,982
Accepted by SEC: 21 Apr 2026, 18:17
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 27 Mar 2026
Transactions: 2
Transaction value: +$60,019
Accepted by SEC: 31 Mar 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 24 Mar 2026
Transactions: 3
Transaction value: +$108,631
Accepted by SEC: 26 Mar 2026, 18:57
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 24 Mar 2026
Transactions: 2
Transaction value: +$2,855,880
Accepted by SEC: 24 Mar 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 18 Mar 2026
Transactions: 2
Transaction value: +$26,214
Accepted by SEC: 20 Mar 2026, 16:54
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 16 Mar 2026
Transactions: 1
Transaction value: +$7,696
Accepted by SEC: 18 Mar 2026, 18:55
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 12 Mar 2026
Transactions: 2
Transaction value: +$75,703
Accepted by SEC: 13 Mar 2026, 18:43
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 06 Mar 2026
Transactions: 2
Transaction value: +$23,760
Accepted by SEC: 10 Mar 2026, 18:47
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 04 Mar 2026
Transactions: 3
Transaction value: +$387,622
Accepted by SEC: 06 Mar 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 03 Mar 2026
Transactions: 4
Transaction value: -$7,846,426
Accepted by SEC: 05 Mar 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 02 Mar 2026
Transactions: 3
Transaction value: +$411,624
Accepted by SEC: 04 Mar 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 27 Feb 2026
Transactions: 1
Transaction value: -$270,900
Accepted by SEC: 03 Mar 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 26 Feb 2026
Transactions: 2
Transaction value: +$25,328
Accepted by SEC: 02 Mar 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ACOG

Alpha Cognition Inc.

Report period: 20 Feb 2026
Transactions: 6
Transaction value: +$1,003,958
Accepted by SEC: 24 Feb 2026, 17:52
Role: 10%+ Owner
Next action: Open filing details

3/A ACOG

Alpha Cognition Inc.

Report period: 19 Feb 2026
Transactions: 0
Transaction value: $0
Accepted by SEC: 20 Feb 2026, 20:24
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 13 Feb 2026
Transactions: 1
Transaction value: +$18,333
Accepted by SEC: 18 Feb 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4/A SLGL

Sol-Gel Technologies Ltd.

Report period: 02 Feb 2026
Transactions: 1
Transaction value: +$5,800
Accepted by SEC: 18 Feb 2026, 12:59
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 27 Jan 2026
Transactions: 1
Transaction value: +$5,705
Accepted by SEC: 29 Jan 2026, 16:16
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 22 Jan 2026
Transactions: 2
Transaction value: +$187,356
Accepted by SEC: 23 Jan 2026, 17:42
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 06 Jan 2026
Transactions: 1
Transaction value: -$1,066,914
Accepted by SEC: 08 Jan 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 02 Jan 2026
Transactions: 2
Transaction value: +$108,858
Accepted by SEC: 06 Jan 2026, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 29 Dec 2025
Transactions: 3
Transaction value: +$2,782,904
Accepted by SEC: 31 Dec 2025, 17:45
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 22 Dec 2025
Transactions: 3
Transaction value: +$120,533
Accepted by SEC: 29 Dec 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 17 Dec 2025
Transactions: 1
Transaction value: +$110,412
Accepted by SEC: 19 Dec 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 12 Dec 2025
Transactions: 1
Transaction value: +$3,480
Accepted by SEC: 16 Dec 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 05 Dec 2025
Transactions: 2
Transaction value: +$29,469
Accepted by SEC: 09 Dec 2025, 16:12
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 01 Dec 2025
Transactions: 2
Transaction value: +$257,610
Accepted by SEC: 03 Dec 2025, 17:39
Role: 10%+ Owner
Next action: Open filing details

4/A CDXS

CODEXIS, INC.

Report period: 26 Nov 2025
Transactions: 6
Transaction value: -$877,846
Accepted by SEC: 15 Dec 2025, 06:06
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 24 Nov 2025
Transactions: 2
Transaction value: +$37,933
Accepted by SEC: 26 Nov 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SLGL

Sol-Gel Technologies Ltd.

Report period: 20 Nov 2025
Transactions: 1
Transaction value: +$207,244
Accepted by SEC: 21 Nov 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

3 SLGL

Sol-Gel Technologies Ltd.

Report period: 13 Nov 2025
Transactions: 0
Transaction value: $0
Accepted by SEC: 17 Nov 2025, 16:15
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 12 Nov 2025
Transactions: 3
Transaction value: +$1,347,184
Accepted by SEC: 14 Nov 2025, 16:15
Role: 10%+ Owner
Next action: Open filing details

4/A CDXS

CODEXIS, INC.

Report period: 07 Nov 2025
Transactions: 6
Transaction value: -$1,868,198
Accepted by SEC: 15 Dec 2025, 06:06
Role: 10%+ Owner
Next action: Open filing details

4 SNWV

SANUWAVE Health, Inc.

Report period: 06 Oct 2025
Transactions: 1
Transaction value: +$38,361
Accepted by SEC: 09 Oct 2025, 19:09
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 31 Jul 2025
Transactions: 2
Transaction value: +$227,921
Accepted by SEC: 04 Aug 2025, 16:38
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 29 Jul 2025
Transactions: 2
Transaction value: +$28,161
Accepted by SEC: 31 Jul 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 18 Jul 2025
Transactions: 1
Transaction value: +$282,000
Accepted by SEC: 22 Jul 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 27 Jun 2025
Transactions: 1
Transaction value: +$239,000
Accepted by SEC: 01 Jul 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 12 Jun 2025
Transactions: 3
Transaction value: +$560,009
Accepted by SEC: 16 Jun 2025, 16:59
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 10 Jun 2025
Transactions: 2
Transaction value: +$125,484
Accepted by SEC: 12 Jun 2025, 16:32
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 09 Jun 2025
Transactions: 2
Transaction value: -$923,827
Accepted by SEC: 11 Jun 2025, 16:15
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 03 Jun 2025
Transactions: 2
Transaction value: -$144,024
Accepted by SEC: 05 Jun 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 23 May 2025
Transactions: 2
Transaction value: +$5,487,000
Accepted by SEC: 28 May 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 12 May 2025
Transactions: 2
Transaction value: -$391,904
Accepted by SEC: 14 May 2025, 16:56
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 30 Apr 2025
Transactions: 2
Transaction value: +$104,096
Accepted by SEC: 02 May 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SNWV

SANUWAVE Health, Inc.

Report period: 29 Apr 2025
Transactions: 2
Transaction value: +$203,875
Accepted by SEC: 30 Apr 2025, 19:06
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 25 Apr 2025
Transactions: 1
Transaction value: +$55,915
Accepted by SEC: 29 Apr 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 15 Apr 2025
Transactions: 3
Transaction value: +$298,772
Accepted by SEC: 17 Apr 2025, 18:07
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 08 Apr 2025
Transactions: 1
Transaction value: +$198,380
Accepted by SEC: 09 Apr 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 01 Apr 2025
Transactions: 3
Transaction value: +$271,788
Accepted by SEC: 03 Apr 2025, 19:39
Role: 10%+ Owner
Next action: Open filing details

4/A HROW

HARROW, INC.

Report period: 24 Mar 2025
Transactions: 1
Transaction value: -$150,055
Accepted by SEC: 14 May 2025, 16:54
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 24 Mar 2025
Transactions: 1
Transaction value: -$150,055
Accepted by SEC: 26 Mar 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 20 Mar 2025
Transactions: 2
Transaction value: +$236,284
Accepted by SEC: 24 Mar 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4/A HROW

HARROW, INC.

Report period: 18 Mar 2025
Transactions: 1
Transaction value: -$148,200
Accepted by SEC: 14 May 2025, 16:54
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 18 Mar 2025
Transactions: 1
Transaction value: -$148,200
Accepted by SEC: 20 Mar 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 13 Mar 2025
Transactions: 1
Transaction value: +$216,155
Accepted by SEC: 14 Mar 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 06 Mar 2025
Transactions: 1
Transaction value: +$261,350
Accepted by SEC: 10 Mar 2025, 17:16
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 04 Mar 2025
Transactions: 2
Transaction value: +$172,273
Accepted by SEC: 06 Mar 2025, 16:51
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 28 Feb 2025
Transactions: 1
Transaction value: -$140,250
Accepted by SEC: 04 Mar 2025, 16:44
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 28 Feb 2025
Transactions: 2
Transaction value: +$574,340
Accepted by SEC: 04 Mar 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 10 Feb 2025
Transactions: 3
Transaction value: +$205,482
Accepted by SEC: 12 Feb 2025, 19:42
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 30 Jan 2025
Transactions: 2
Transaction value: +$282,967
Accepted by SEC: 31 Jan 2025, 19:08
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 22 Jan 2025
Transactions: 1
Transaction value: -$711,814
Accepted by SEC: 24 Jan 2025, 21:29
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 30 Dec 2024
Transactions: 2
Transaction value: +$210,994
Accepted by SEC: 02 Jan 2025, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 SNWV

SANUWAVE Health, Inc.

Report period: 30 Oct 2024
Transactions: 5
Transaction value: +$438,902
Accepted by SEC: 01 Nov 2024, 19:47
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 25 Oct 2024
Transactions: 1
Transaction value: +$72,720
Accepted by SEC: 28 Oct 2024, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 23 Oct 2024
Transactions: 1
Transaction value: +$79,814
Accepted by SEC: 25 Oct 2024, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 04 Oct 2024
Transactions: 6
Transaction value: +$434,137
Accepted by SEC: 08 Oct 2024, 18:34
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 24 Sep 2024
Transactions: 2
Transaction value: +$249,146
Accepted by SEC: 26 Sep 2024, 15:21
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 20 Sep 2024
Transactions: 3
Transaction value: +$3,308,034
Accepted by SEC: 23 Sep 2024, 17:19
Role: 10%+ Owner
Next action: Open filing details

4 CDXS

CODEXIS, INC.

Report period: 18 Sep 2024
Transactions: 2
Transaction value: +$192,992
Accepted by SEC: 19 Sep 2024, 18:16
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 11 Sep 2024
Transactions: 4
Transaction value: -$271,715
Accepted by SEC: 12 Sep 2024, 20:20
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 10 Sep 2024
Transactions: 4
Transaction value: +$504,875
Accepted by SEC: 12 Sep 2024, 19:31
Role: 10%+ Owner
Next action: Open filing details

3 ETON

Eton Pharmaceuticals, Inc.

Report period: 09 Sep 2024
Transactions: 0
Transaction value: $0
Accepted by SEC: 12 Sep 2024, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 09 Sep 2024
Transactions: 4
Transaction value: -$114,251
Accepted by SEC: 10 Sep 2024, 19:11
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 16 Jul 2024
Transactions: 2
Transaction value: -$27,828
Accepted by SEC: 18 Jul 2024, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 09 Jul 2024
Transactions: 6
Transaction value: -$175,842
Accepted by SEC: 11 Jul 2024, 19:56
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 01 Jul 2024
Transactions: 2
Transaction value: -$17,598
Accepted by SEC: 03 Jul 2024, 14:00
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 27 Jun 2024
Transactions: 4
Transaction value: -$142,503
Accepted by SEC: 28 Jun 2024, 18:45
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 25 Jun 2024
Transactions: 2
Transaction value: -$28,734
Accepted by SEC: 27 Jun 2024, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 30 May 2024
Transactions: 2
Transaction value: -$44,008
Accepted by SEC: 31 May 2024, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 21 May 2024
Transactions: 4
Transaction value: -$130,434
Accepted by SEC: 23 May 2024, 19:01
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 17 May 2024
Transactions: 4
Transaction value: -$230,326
Accepted by SEC: 17 May 2024, 19:48
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 09 May 2024
Transactions: 2
Transaction value: -$566,951
Accepted by SEC: 10 May 2024, 18:57
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 25 Apr 2024
Transactions: 1
Transaction value: +$199,400
Accepted by SEC: 25 Apr 2024, 17:19
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 23 Apr 2024
Transactions: 2
Transaction value: +$204,640
Accepted by SEC: 24 Apr 2024, 16:40
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 19 Apr 2024
Transactions: 1
Transaction value: +$310,390
Accepted by SEC: 19 Apr 2024, 18:24
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 28 Mar 2024
Transactions: 1
Transaction value: +$641,000
Accepted by SEC: 28 Mar 2024, 18:07
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 20 Mar 2024
Transactions: 1
Transaction value: +$488,290
Accepted by SEC: 22 Mar 2024, 11:52
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 10 Nov 2023
Transactions: 2
Transaction value: -$1,401,571
Accepted by SEC: 14 Nov 2023, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW, INC.

Report period: 19 Sep 2023
Transactions: 1
Transaction value: +$200,735
Accepted by SEC: 16 Nov 2023, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 19 Sep 2023
Transactions: 2
Transaction value: +$292,076
Accepted by SEC: 20 Sep 2023, 18:39
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 20 Apr 2023
Transactions: 0
Transaction value: $0
Accepted by SEC: 20 Apr 2023, 16:05
Role: Former 10% Owner.
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 09 Mar 2023
Transactions: 1
Transaction value: +$240,821
Accepted by SEC: 13 Mar 2023, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 30 Dec 2022
Transactions: 2
Transaction value: +$41,949
Accepted by SEC: 30 Dec 2022, 17:00
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 14 Dec 2022
Transactions: 2
Transaction value: +$209,876
Accepted by SEC: 16 Dec 2022, 16:03
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 14 Dec 2022
Transactions: 2
Transaction value: +$4,536,045
Accepted by SEC: 14 Dec 2022, 15:05
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 06 Dec 2022
Transactions: 3
Transaction value: -$2,216
Accepted by SEC: 08 Dec 2022, 17:49
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 03 Nov 2022
Transactions: 2
Transaction value: +$158,285
Accepted by SEC: 04 Nov 2022, 16:03
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 18 Oct 2022
Transactions: 2
Transaction value: +$20,625
Accepted by SEC: 19 Oct 2022, 19:22
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 11 Oct 2022
Transactions: 2
Transaction value: +$128,000
Accepted by SEC: 11 Oct 2022, 19:29
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 29 Sep 2022
Transactions: 1
Transaction value: +$16,370
Accepted by SEC: 03 Oct 2022, 16:06
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 28 Sep 2022
Transactions: 2
Transaction value: +$108,354
Accepted by SEC: 30 Sep 2022, 06:15
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 27 Sep 2022
Transactions: 1
Transaction value: +$2,877
Accepted by SEC: 28 Sep 2022, 18:00
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 23 Sep 2022
Transactions: 2
Transaction value: +$54,393
Accepted by SEC: 26 Sep 2022, 16:05
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 22 Sep 2022
Transactions: 2
Transaction value: +$29,943
Accepted by SEC: 22 Sep 2022, 18:09
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 20 Sep 2022
Transactions: 1
Transaction value: +$18,524
Accepted by SEC: 20 Sep 2022, 17:37
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 19 Sep 2022
Transactions: 2
Transaction value: +$145,584
Accepted by SEC: 19 Sep 2022, 19:27
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 19 Sep 2022
Transactions: 1
Transaction value: +$9,366
Accepted by SEC: 19 Sep 2022, 19:00
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 15 Sep 2022
Transactions: 4
Transaction value: +$52,853
Accepted by SEC: 16 Sep 2022, 17:47
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 14 Sep 2022
Transactions: 4
Transaction value: +$93,808
Accepted by SEC: 15 Sep 2022, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 13 Sep 2022
Transactions: 2
Transaction value: +$42,285
Accepted by SEC: 15 Sep 2022, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 16 Aug 2022
Transactions: 2
Transaction value: +$2,520,000
Accepted by SEC: 16 Aug 2022, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 10 Aug 2022
Transactions: 2
Transaction value: +$102,089
Accepted by SEC: 12 Aug 2022, 06:41
Role: 10%+ Owner
Next action: Open filing details

4/A TELA

TELA Bio, Inc.

Report period: 01 Aug 2022
Transactions: 2
Transaction value: +$39,632
Accepted by SEC: 12 Aug 2022, 09:27
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 26 Jul 2022
Transactions: 1
Transaction value: +$3,877
Accepted by SEC: 26 Jul 2022, 17:25
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 22 Jul 2022
Transactions: 2
Transaction value: +$41,709
Accepted by SEC: 22 Jul 2022, 17:48
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 21 Jul 2022
Transactions: 2
Transaction value: +$83,010
Accepted by SEC: 21 Jul 2022, 17:50
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 20 Jul 2022
Transactions: 2
Transaction value: +$41,192
Accepted by SEC: 20 Jul 2022, 18:55
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 15 Jul 2022
Transactions: 1
Transaction value: +$21,068
Accepted by SEC: 15 Jul 2022, 18:06
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 14 Jul 2022
Transactions: 1
Transaction value: +$13,024
Accepted by SEC: 14 Jul 2022, 18:25
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 01 Jul 2022
Transactions: 1
Transaction value: +$1,400
Accepted by SEC: 05 Jul 2022, 18:30
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 29 Jun 2022
Transactions: 3
Transaction value: +$24,969
Accepted by SEC: 30 Jun 2022, 19:20
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 24 Jun 2022
Transactions: 1
Transaction value: +$15,894
Accepted by SEC: 27 Jun 2022, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 24 Jun 2022
Transactions: 2
Transaction value: +$16,776
Accepted by SEC: 24 Jun 2022, 19:45
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 22 Jun 2022
Transactions: 2
Transaction value: +$340,574
Accepted by SEC: 22 Jun 2022, 17:18
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 21 Jun 2022
Transactions: 1
Transaction value: +$1,105,279
Accepted by SEC: 23 Jun 2022, 18:54
Role: 10%+ Owner
Next action: Open filing details

4 TELA

TELA Bio, Inc.

Report period: 10 Jun 2022
Transactions: 2
Transaction value: +$154,066
Accepted by SEC: 10 Jun 2022, 18:16
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 10 May 2022
Transactions: 2
Transaction value: +$17,032
Accepted by SEC: 10 May 2022, 19:58
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 29 Apr 2022
Transactions: 2
Transaction value: +$14,058
Accepted by SEC: 29 Apr 2022, 18:27
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 22 Apr 2022
Transactions: 4
Transaction value: +$117,438
Accepted by SEC: 25 Apr 2022, 17:55
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 13 Apr 2022
Transactions: 4
Transaction value: +$50,091
Accepted by SEC: 14 Apr 2022, 18:13
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 12 Apr 2022
Transactions: 4
Transaction value: +$279,502
Accepted by SEC: 13 Apr 2022, 18:33
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 11 Apr 2022
Transactions: 4
Transaction value: +$66,846
Accepted by SEC: 12 Apr 2022, 19:38
Role: 10%+ Owner
Next action: Open filing details

4/A TARA

Protara Therapeutics, Inc.

Report period: 07 Apr 2022
Transactions: 4
Transaction value: +$48,487
Accepted by SEC: 15 Apr 2022, 06:15
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 16 Mar 2022
Transactions: 1
Transaction value: +$4,917
Accepted by SEC: 17 Mar 2022, 16:05
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 28 Jan 2022
Transactions: 2
Transaction value: +$119,271
Accepted by SEC: 31 Jan 2022, 15:05
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 28 Jan 2022
Transactions: 1
Transaction value: +$1,100
Accepted by SEC: 31 Jan 2022, 15:05
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 28 Jan 2022
Transactions: 2
Transaction value: +$43,686
Accepted by SEC: 31 Jan 2022, 15:05
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 21 Jan 2022
Transactions: 4
Transaction value: +$112,414
Accepted by SEC: 24 Jan 2022, 17:18
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 19 Jan 2022
Transactions: 4
Transaction value: +$101,032
Accepted by SEC: 21 Jan 2022, 15:00
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 29 Dec 2021
Transactions: 2
Transaction value: +$131,362
Accepted by SEC: 29 Dec 2021, 18:14
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 28 Dec 2021
Transactions: 3
Transaction value: +$76,498
Accepted by SEC: 29 Dec 2021, 18:36
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 27 Dec 2021
Transactions: 4
Transaction value: +$308,052
Accepted by SEC: 29 Dec 2021, 15:05
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 23 Dec 2021
Transactions: 4
Transaction value: +$248,293
Accepted by SEC: 27 Dec 2021, 17:52
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 20 Dec 2021
Transactions: 1
Transaction value: +$4,562
Accepted by SEC: 22 Dec 2021, 15:05
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 16 Dec 2021
Transactions: 4
Transaction value: +$66,899
Accepted by SEC: 20 Dec 2021, 15:00
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 01 Dec 2021
Transactions: 2
Transaction value: +$53,287
Accepted by SEC: 16 Dec 2021, 15:01
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 01 Dec 2021
Transactions: 4
Transaction value: +$146,498
Accepted by SEC: 15 Dec 2021, 15:05
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 01 Dec 2021
Transactions: 4
Transaction value: +$256,385
Accepted by SEC: 07 Dec 2021, 15:05
Role: 10%+ Owner
Next action: Open filing details

Tracon Pharmaceuticals, Inc.

Report period: 01 Dec 2021
Transactions: 4
Transaction value: +$144,820
Accepted by SEC: 03 Dec 2021, 16:14
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 17 Nov 2021
Transactions: 4
Transaction value: +$169,774
Accepted by SEC: 19 Nov 2021, 15:10
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 17 Nov 2021
Transactions: 1
Transaction value: -$116,712
Accepted by SEC: 19 Nov 2021, 15:09
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 15 Nov 2021
Transactions: 4
Transaction value: -$74,877
Accepted by SEC: 17 Nov 2021, 15:33
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 05 Nov 2021
Transactions: 4
Transaction value: -$1,377,986
Accepted by SEC: 09 Nov 2021, 15:46
Role: 10%+ Owner
Next action: Open filing details

4 TARA

Protara Therapeutics, Inc.

Report period: 04 Nov 2021
Transactions: 2
Transaction value: +$42,620
Accepted by SEC: 08 Nov 2021, 13:30
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 03 Nov 2021
Transactions: 4
Transaction value: -$1,312,501
Accepted by SEC: 05 Nov 2021, 16:13
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 08 Oct 2021
Transactions: 6
Transaction value: -$830,670
Accepted by SEC: 13 Oct 2021, 07:57
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 19 Aug 2021
Transactions: 2
Transaction value: +$443,362
Accepted by SEC: 23 Aug 2021, 17:59
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 17 Aug 2021
Transactions: 4
Transaction value: +$624,697
Accepted by SEC: 19 Aug 2021, 19:10
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 04 Aug 2021
Transactions: 6
Transaction value: -$3,523,187
Accepted by SEC: 06 Aug 2021, 21:53
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 19 Jul 2021
Transactions: 6
Transaction value: +$146,290
Accepted by SEC: 22 Jul 2021, 09:19
Role: 10%+ Owner
Next action: Open filing details

4 HROW

HARROW HEALTH, INC.

Report period: 17 Jun 2021
Transactions: 4
Transaction value: +$622,389
Accepted by SEC: 22 Jun 2021, 11:44
Role: 10%+ Owner
Next action: Open filing details

4/A ETON

Eton Pharmaceuticals, Inc.

Report period: 15 Jun 2021
Transactions: 2
Transaction value: -$847,350
Accepted by SEC: 21 Jun 2021, 06:05
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 26 May 2021
Transactions: 2
Transaction value: -$847,350
Accepted by SEC: 17 Jun 2021, 16:39
Role: 10%+ Owner
Next action: Open filing details

4 ETON

Eton Pharmaceuticals, Inc.

Report period: 25 May 2021
Transactions: 6
Transaction value: -$2,064,511
Accepted by SEC: 27 May 2021, 19:34
Role: 10%+ Owner
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Opaleye Management Inc.

Insider Reports Filed by Opaleye Management Inc.